AUTONOMIX MEDICAL INC. - COMMON STOCK

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

03 Jul 2024 09:00:00 By Nasdaq GlobeNewswire

Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial

18 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

17 Jun 2024 16:05:00 By Nasdaq GlobeNewswire

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024

10 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

03 Jun 2024 08:15:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

31 May 2024 08:05:00 By Nasdaq GlobeNewswire

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

23 May 2024 09:15:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

14 May 2024 16:15:00 By Nasdaq GlobeNewswire

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip

25 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

24 Apr 2024 09:00:00 By Nasdaq GlobeNewswire

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

16 Apr 2024 09:00:00 By Nasdaq GlobeNewswire

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

09 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

08 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

27 Mar 2024 09:00:00 By Nasdaq GlobeNewswire

 Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

20 Mar 2024 08:05:00 By Nasdaq GlobeNewswire

Autonomix Appoints Jennifer Cook as Chief Business Officer

19 Mar 2024 08:45:00 By Nasdaq GlobeNewswire

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

14 Mar 2024 08:15:00 By Nasdaq GlobeNewswire

Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

06 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial

29 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity

23 Feb 2024 08:50:00 By Nasdaq GlobeNewswire